A randomized, four-way cross-over, double-blind, controlled study of oral donepezil (2, 5, 10 mg) in patients with moderate to severe obstructive sleep apnea.
Phase of Trial: Phase II
Latest Information Update: 14 May 2011
At a glance
- Drugs Donepezil (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 14 May 2011 New trial record